Bone Disease News - Latest Updates & Headlines
Celltrion's bone disease biosimilars get approval in US
Seoul, March 4: Celltrion, a major South Korean biopharmaceutical firm, said on Tuesday its two new bio-similars for bone disease treatment have obtained approval from the United States.